Back to BAX Stock Lookup
Pages: 1 2 »» Last Page

Baxter (BAX) – Press Releases

Feb 3, 2016 04:15 PM Baxter to Present at the RBC Capital Markets 2016 Global Healthcare Conference
Feb 2, 2016 07:00 AM Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook
Jan 20, 2016 04:15 PM Baxter to Present at The Leerink Partners 5th Annual Global Healthcare Conference
Jan 19, 2016 09:00 AM Massachusetts General Hospital in Boston Receives Prestigious Foster G. McGaw Prize for Excellence in Community Service
Jan 6, 2016 04:15 PM Baxter International Fourth Quarter 2015 Financial Results Conference Call
Dec 21, 2015 04:15 PM Baxter to Present at the 36th Annual JP Morgan Healthcare Conference
Nov 10, 2015 08:55 AM Baxter Declares Quarterly Dividend
Nov 4, 2015 04:15 PM Baxter to Present at the Stifel 2015 Healthcare Conference
Nov 4, 2015 09:00 AM Baxter Recognized as a Sustainability Leader, Develops Future Leaders and Launches New Environmental Initiatives
Oct 28, 2015 04:46 PM Baxter Names José Almeida Chairman and CEO
Oct 27, 2015 06:42 AM Baxter Reports Strong Third Quarter Financial Results Exceeding Previously Issued Guidance
Oct 22, 2015 04:15 PM Baxter to Present at the Credit Suisse Healthcare Conference
Oct 21, 2015 09:00 AM Baxter Appoints Michael F. Mahoney to Its Board
Oct 13, 2015 08:00 AM Baxter Announces U.S. FDA Clearance for AMIA Automated Peritoneal Dialysis System with SHARESOURCE Connectivity Platform
Oct 1, 2015 04:15 PM Baxter International Third Quarter 2015 Financial Results Conference Call
Sep 30, 2015 09:00 AM Baxter Appoints Munib Islam to Board; Announces Agreement with Third Point
Sep 16, 2015 09:00 AM The Honor Society of Nursing, Sigma Theta Tau International Names Dr. Jacquelyn Campbell as its 2015 Episteme Award Recipient
Sep 14, 2015 04:15 PM Baxter to Present at the Morgan Stanley Global Healthcare Conference
Sep 9, 2015 07:00 AM Xenetic Biosciences (XBIO) Contracts With Baxter International Inc Have Been Assigned to Baxalta Incorporated Following the Company Spin Out
Sep 3, 2015 04:15 PM Baxter to Present at the Morgan Stanley Global Healthcare Conference
Sep 1, 2015 05:26 PM Baxalta Files Registration Statement for Secondary Offering of Common Stock in Connection with the Exercise of Demand Registration Rights by Baxter
Aug 14, 2015 09:00 AM Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix
Aug 6, 2015 04:01 PM Baxalta Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital
Aug 5, 2015 03:17 PM Baxter Comments on Schedule 13D Filing by Third Point
Aug 4, 2015 03:47 PM Baxalta Confirms Receipt of Highly Conditional, Unsolicited Proposal from Shire
Aug 4, 2015 07:30 AM Shire Proposes Combination With Baxalta to Create the Leading Global Biotech Company Focused on Rare Diseases
Aug 3, 2015 09:00 AM Blood Publishes Phase III Data on Baxalta’s Investigational Treatment for Von Willebrand Disease, the Most Common Type of Inherited Bleeding Disorder
Aug 3, 2015 08:30 AM Baxalta Announces Expanded CMS Coverage for Medicare PI Patients to Receive At-Home Treatment with HYQVIA
Jul 30, 2015 07:00 AM Baxalta Reports Positive Sales Momentum in Second Quarter of 2015, Raises Financial Guidance for Second Half of 2015
Jul 29, 2015 04:10 PM Baxter Declares Quarterly Dividend
Jul 29, 2015 04:05 PM Baxter Reports Strong Second Quarter Financial Results Exceeding Guidance
Jul 28, 2015 04:06 PM Baxalta Board of Directors Declares Inaugural Dividend; Approves $1 Billion Share Repurchase Authorization
Jul 27, 2015 08:30 AM Baxalta’s OBIZUR for Acquired Hemophilia A Receives Positive Opinion from European Committee for Medicinal Products for Human Use (CHMP)
Jul 23, 2015 08:30 AM Baxalta Completes ONCASPAR Portfolio Acquisition, Aims to Broaden Patient Access to Leading Treatment for Leukemia
Jul 16, 2015 03:36 PM Baxalta's BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A
Jul 16, 2015 08:30 AM Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A
Jul 16, 2015 08:30 AM CORRECTING and REPLACING Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A
Jul 9, 2015 04:30 PM Baxalta to Host First Investor Conference Call on July 30, 2015
Jul 9, 2015 08:30 AM Baxalta Appoints Two New Directors to the Board, Further Diversifying With Strong Biopharmaceutical Leadership Experience
Jul 8, 2015 04:15 PM Baxter International Second Quarter 2015 Financial Results Conference Call
Jul 2, 2015 08:00 AM Baxter Announces Early Results of Debt Tender Offers
Jul 1, 2015 04:46 PM Baxter Announces Pricing of Debt Tender Offers
Jun 25, 2015 03:18 PM MM-398 Receiving the Priority Review Designation by US FDA for New Drug Application and the Acceptance of Market Authorization Application by EMA in Post-Gemcitabine Metastatic Pancreatic Cancer
Jun 25, 2015 07:00 AM U.S. FDA Grants Priority Review for MM-398 New Drug Application
Jun 24, 2015 09:00 AM Baxalta Reports Continued Progress on Phase 1/2 Clinical Trial of BAX335, Investigational Gene Therapy Treatment for Hemophilia B
Jun 22, 2015 06:30 AM Kamada Collaborates with Baxalta on Phase 1/2 Clinical Trial with Alpha-1 Antitrypsin for the Prevention of Lung Transplant Rejection
Jun 19, 2015 06:13 PM The Priceline Group Set to Join the S&P 100; Baxalta to Join the 500; Other Changes to S&P MidCap 400 & S&P SmallCap 600
Jun 19, 2015 09:00 AM Baxalta Demonstrates Commitment to Innovation in Hemophilia and Blood Disorders at ISTH 2015 Congress
Jun 19, 2015 08:00 AM Baxalta Announces Pricing of $5 Billion Private Placement Notes Offering
Jun 18, 2015 08:30 AM Baxter Announces Debt Tender Offers
Pages: 1 2 »» Last Page

Back to BAX Stock Lookup